Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 162 | 2 | 199 | +39 |
| Shares | 65.6M | 1.90M | 87.6M | +23.9M (+37.6%) |
| Value | $222.2M | $6.46M | $480.9M | +$265.1M (+122.9%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (57)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (18)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| AIGH Capital Management LLC | 2,574,846 | $8.73M |
| Caxton Corp | 2,015,157 | $6.83M |
| Fairfax Financial Holdings LtdSuperinvestorFairfax Financial | 139,687 | $472.1K |
| Rossby Financial, LCC | 35,000 | $118.7K |
| CI Private Wealth, LLC | 25,200 | $85.4K |
| Powell Investment Advisors, LLC | 25,000 | $84.8K |
| Janney Montgomery Scott LLC | 23,000 | $78.0K |
| Savant Capital, LLC | 22,116 | $75.0K |
| Virtus ETF Advisers LLC | 20,910 | $70.9K |
| Virtu Financial LLC | 17,137 | $58.0K |
| Aquatic Capital Management LLC | 14,684 | $49.8K |
| Deltec Asset Management LLC | 14,000 | $47.5K |
| Bleakley Financial Group, LLC | 10,536 | $35.7K |
| Parallel Advisors, LLC | 3,294 | $11.2K |
| GWM Advisors LLC | 10,000 | $10.7K |
| BFSG, LLC | 2,000 | $6.78K |
| SRS Capital Advisors, Inc. | 1,632 | $5.53K |
| Truvestments Capital LLC | 847 | $2.87K |
Not filed for Q1 2025 yet (2)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 1,903,442 | $6.45M |
| Global Retirement Partners, LLC | 1,113 | $3.77K |